At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Potential for Improved Analgesia From Combined Medication for Superficial Pain
In Brief
A Phase 3 clinical trial evaluating Diclofenac and Atropine combination drug and Placebo for Pain. Completed, enrolled 100 participants across 1 site.
Detailed Summary
This research study is being done to assess if a combination of medications can enhance the relief of superficial pain (pain at the surface of the skin, such as sunburn pain). The investigators also want to find out if certain genes may be linked to individual differences in experienced efficacy of pain killers. The combination of medications under investigation is diclofenac and atropine. Diclofenac has been approved by the U.S. Food and Drug Administration (FDA) to treat pain. Atropine has been approved by the FDA to treat certain types of poisoning, heartbeat problems, and other diseases but atropine is not approved to treat pain. However, atropine has been used for many years in different European countries to treat painful conditions such as stomach cramps.This research study will compare diclofenac and atropine to placebo.
Study Details
Timeline
Interventions
Diclofenac will be associated with a small dose of atropine 1.2mg
For each capsule of active medication, a capsule of placebo will be provided, identical looking.